• Tchaikapharma registers new antithrombotic product

    June 13, 2022

    Tchaikapharma has expanded its portfolio with another product, namely Fluidoro 10 mg film-coated tablets (with active ingredient prasugrel). It belongs to a group of drugs called platelet antiaggregants – it inhibits the accumulation of platelets and thus reduces the risk of blood clots.


    Fluidoro, given concomitantly with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (e.g., unstable angina, non-ST segment elevation myocardial infarction, or ST segment elevation myocardial infarction undergoing primary or delayed percutaneous coronary intervention (PCI).


    The medicinal product is available on prescription.


    ATC code: B01AC22